Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
The Journal of Biological Chemistry|November 26, 2020
A second mechanism employed by artemisinins to suppress Plasmodium falciparum hinges on inhibition of hematin crystallizationWenchuan Ma, Victoria A Balta, Rachel West, et al.
Plos One|July 16, 2021
Self-management for chronic widespread pain including fibromyalgia: A systematic review and meta-analysisAdam W A Geraghty, Emma Maund, David Newell, et al.
JMIR Research Protocols|September 11, 2020
Work2Prevent, an Employment Intervention Program as HIV Prevention for Young Men Who Have Sex With Men and Transgender Youth of Color (Phase 3): Protocol for a Single-Arm Community-Based Trial to Assess Feasibility and Acceptability in a Real-World SettingBrandon J Hill, Darnell N Motley, Kris Rosentel, et al.
Alimentary Pharmacology & Therapeutics|July 31, 2019
Real-life study of safety of thiopurine-allopurinol combination therapy in inflammatory bowel disease: myelotoxicity and hepatotoxicity rarely affect maintenance treatmentJoany E Kreijne, Rozanne C de Veer, Nanne K de Boer, et al.
Digestive Diseases and Sciences|April 16, 2025
Obesity Is Associated with Inferior Clinical Treatment Outcomes in Inflammatory Bowel Disease: A Nationwide Dutch Registry StudyDorien Oomkens, Zlatan Mujagic, Annemarie de Vries, et al.
United European Gastroenterology Journal|October 14, 2024
Cost-effectiveness and cost-utility of optimized mercaptopurine treatment versus placebo in ulcerative colitis patients: The randomized controlled OPTIC trialMark Löwenberg, Marit van Barreveld, Adriaan Volkers, et al.
BMJ Open|March 18, 2018
Role of viral and bacterial pathogens in causing pneumonia among Western Australian children: a case-control study protocolMejbah Uddin Bhuiyan, Thomas L Snelling, Rachel West, et al.
Journal of Crohn'S & Colitis|February 27, 2023
Mercaptopurine for the Treatment of Ulcerative Colitis: A Randomized Placebo-Controlled TrialMark Löwenberg, Adriaan Volkers, Sara van Gennep, et al.
Alimentary Pharmacology & Therapeutics|April 29, 2020
Limited added value of laboratory monitoring in thiopurine maintenance monotherapy in inflammatory bowel disease patientsJoany E Kreijne, Annemarie C de Vries, Rozanne C de Veer, et al.
The Lancet. Gastroenterology & Hepatology|January 9, 2026
Appendicectomy versus switching to a JAK inhibitor in inducing remission in patients with active ulcerative colitis after biologic therapy failure (COSTA): 1-year results of a multicentre, prospective, cohort studyEva Visser, Maud A Reijntjes, Lianne Heuthorst, et al.
Pageof 4